Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 3 of 3 entries
Sorted by: Best Match Show Resources per page
Structure Activity Relationships for a Series of Eticlopride-Based Dopamine D.

Journal of medicinal chemistry

Shaik AB, Boateng CA, Battiti FO, Bonifazi A, Cao J, Chen L, Chitsazi R, Ravi S, Lee KH, Shi L, Newman AH.
PMID: 34636551
J Med Chem. 2021 Oct 28;64(20):15313-15333. doi: 10.1021/acs.jmedchem.1c01353. Epub 2021 Oct 12.

The crystal structure of the dopamine D

Cite
Shaik AB, Boateng CA, Battiti FO, et al. Structure Activity Relationships for a Series of Eticlopride-Based Dopamine D. J Med Chem. 2021;64(20):15313-15333doi: 10.1021/acs.jmedchem.1c01353.
Shaik, A. B., Boateng, C. A., Battiti, F. O., Bonifazi, A., Cao, J., Chen, L., Chitsazi, R., Ravi, S., Lee, K. H., Shi, L., & Newman, A. H. (2021). Structure Activity Relationships for a Series of Eticlopride-Based Dopamine D. Journal of medicinal chemistry, 64(20), 15313-15333. https://doi.org/10.1021/acs.jmedchem.1c01353
Shaik, Anver Basha, et al. "Structure Activity Relationships for a Series of Eticlopride-Based Dopamine D." Journal of medicinal chemistry vol. 64,20 (2021): 15313-15333. doi: https://doi.org/10.1021/acs.jmedchem.1c01353
Shaik AB, Boateng CA, Battiti FO, Bonifazi A, Cao J, Chen L, Chitsazi R, Ravi S, Lee KH, Shi L, Newman AH. Structure Activity Relationships for a Series of Eticlopride-Based Dopamine D. J Med Chem. 2021 Oct 28;64(20):15313-15333. doi: 10.1021/acs.jmedchem.1c01353. Epub 2021 Oct 12. PMID: 34636551.
Copy Download .nbib Format: NLM
Exception That Proves the Rule: Investigation of Privileged Stereochemistry in Designing Dopamine D.

ACS medicinal chemistry letters

Battiti FO, Newman AH, Bonifazi A.
PMID: 33062179
ACS Med Chem Lett. 2020 Feb 28;11(10):1956-1964. doi: 10.1021/acsmedchemlett.9b00660. eCollection 2020 Oct 08.

In this study, starting from our selective D

Cite
Battiti FO, Newman AH, Bonifazi A. Exception That Proves the Rule: Investigation of Privileged Stereochemistry in Designing Dopamine D. ACS Med Chem Lett. 2020;11(10):1956-1964doi: 10.1021/acsmedchemlett.9b00660.
Battiti, F. O., Newman, A. H., & Bonifazi, A. (2020). Exception That Proves the Rule: Investigation of Privileged Stereochemistry in Designing Dopamine D. ACS medicinal chemistry letters, 11(10), 1956-1964. https://doi.org/10.1021/acsmedchemlett.9b00660
Battiti, Francisco O, et al. "Exception That Proves the Rule: Investigation of Privileged Stereochemistry in Designing Dopamine D." ACS medicinal chemistry letters vol. 11,10 (2020): 1956-1964. doi: https://doi.org/10.1021/acsmedchemlett.9b00660
Battiti FO, Newman AH, Bonifazi A. Exception That Proves the Rule: Investigation of Privileged Stereochemistry in Designing Dopamine D. ACS Med Chem Lett. 2020 Feb 28;11(10):1956-1964. doi: 10.1021/acsmedchemlett.9b00660. eCollection 2020 Oct 08. PMID: 33062179; PMCID: PMC7549273.
Copy Download .nbib Format: NLM
Chiral Cyclic Aliphatic Linkers as Building Blocks for Selective Dopamine D.

Journal of medicinal chemistry

Battiti FO, Zaidi SA, Katritch V, Newman AH, Bonifazi A.
PMID: 34699207
J Med Chem. 2021 Nov 11;64(21):16088-16105. doi: 10.1021/acs.jmedchem.1c01433. Epub 2021 Oct 26.

Linkers are emerging as a key component in regulating the pharmacology of bitopic ligands directed toward G-protein coupled receptors (GPCRs). In this study, the role of regio- and stereochemistry in cyclic aliphatic linkers tethering well-characterized primary and secondary pharmacophores...

Cite
Battiti FO, Zaidi SA, Katritch V, et al. Chiral Cyclic Aliphatic Linkers as Building Blocks for Selective Dopamine D. J Med Chem. 2021;64(21):16088-16105doi: 10.1021/acs.jmedchem.1c01433.
Battiti, F. O., Zaidi, S. A., Katritch, V., Newman, A. H., & Bonifazi, A. (2021). Chiral Cyclic Aliphatic Linkers as Building Blocks for Selective Dopamine D. Journal of medicinal chemistry, 64(21), 16088-16105. https://doi.org/10.1021/acs.jmedchem.1c01433
Battiti, Francisco O, et al. "Chiral Cyclic Aliphatic Linkers as Building Blocks for Selective Dopamine D." Journal of medicinal chemistry vol. 64,21 (2021): 16088-16105. doi: https://doi.org/10.1021/acs.jmedchem.1c01433
Battiti FO, Zaidi SA, Katritch V, Newman AH, Bonifazi A. Chiral Cyclic Aliphatic Linkers as Building Blocks for Selective Dopamine D. J Med Chem. 2021 Nov 11;64(21):16088-16105. doi: 10.1021/acs.jmedchem.1c01433. Epub 2021 Oct 26. PMID: 34699207.
Copy Download .nbib Format: NLM
Showing 1 to 3 of 3 entries